L
Laurent Mesnard
Researcher at University of Paris
Publications - 118
Citations - 2493
Laurent Mesnard is an academic researcher from University of Paris. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 21, co-authored 82 publications receiving 2034 citations. Previous affiliations of Laurent Mesnard include Cornell University & Pierre-and-Marie-Curie University.
Papers
More filters
Journal ArticleDOI
Improved survival of critically ill cancer patients with septic shock
Jérôme Larché,Elie Azoulay,Fabienne Fieux,Laurent Mesnard,Delphine Moreau,Guillaume Thiery,Michael Darmon,Jean-Roger Le Gall,Benoît Schlemmer +8 more
TL;DR: Earlier ICU admission and antibiotic treatment of critically ill cancer patients with septic shock is associated with higher 30-day survival, and the LOD score change on day 3 as compared to admission is useful for predicting survival.
Journal ArticleDOI
Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis
Guillaume Bollée,Martin Flamant,Sandra Schordan,Cécile Fligny,Cécile Fligny,Elisabeth Rumpel,Marine Milon,Marine Milon,Eric Schordan,Nathalie Sabaa,Nathalie Sabaa,Sophie Vandermeersch,Sophie Vandermeersch,Ariane Galaup,Ariane Galaup,Anita Rodenas,Ibrahim Casal,Ibrahim Casal,Susan W. Sunnarborg,David J. Salant,Jeffrey B. Kopp,David W. Threadgill,Susan E. Quaggin,Jean Claude Dussaule,Jean Claude Dussaule,Stéphane Germain,Stéphane Germain,Laurent Mesnard,Laurent Mesnard,Karlhans Endlich,Claude Boucheix,Claude Boucheix,Xavier Belenfant,Patrice Callard,Nicole Endlich,Pierre-Louis Tharaux,Pierre-Louis Tharaux +36 more
TL;DR: De novo induction of heparin-binding epidermal growth factor–like growth factor in intrinsic glomerular epithelial cells (podocytes) from both mice and humans with RPGN is shown and targeting the HB-EGF–EGFR pathway could also be beneficial in treatment of human RPGN.
Journal ArticleDOI
Targeting the Calpain/Calpastatin System as a New Strategy to Prevent Cardiovascular Remodeling in Angiotensin II–Induced Hypertension
Emmanuel Letavernier,Joëlle Perez,Agnès Bellocq,Laurent Mesnard,Alexandre C. Keller,Jean-Philippe Haymann,Laurent Baud +6 more
TL;DR: Results indicate a critical role for calpains as downstream mediators in Ang II–induced cardiovascular remodeling and, thus, highlight an attractive therapeutic target.
Journal ArticleDOI
Early Epithelial Phenotypic Changes Predict Graft Fibrosis
Alexandre Hertig,Dany Anglicheau,Jérôme Verine,Nicolas Pallet,Maxime Touzot,Pierre-Yves Ancel,Laurent Mesnard,Nicole Brousse,Edith Baugey,Denis Glotz,Christophe Legendre,Eric Rondeau,Yi-Chun Xu-Dubois +12 more
TL;DR: Early phenotypic changes indicative of epithelial-to-mesenchymal transition predict the progression toward interstitial fibrosis in human renal allografts.
Journal ArticleDOI
Autoantibodies specific for the phospholipase A2 receptor in recurrent and De Novo membranous nephropathy.
Hanna Debiec,Hanna Debiec,L. Martin,Chantal Jouanneau,Chantal Jouanneau,G. Dautin,Laurent Mesnard,Laurent Mesnard,Eric Rondeau,Eric Rondeau,Christiane Mousson,Pierre Ronco,Pierre Ronco +12 more
TL;DR: There is evidence that some patients with PLA2R1‐related idiopathic MN and anti‐PLA2 R1 antibodies at the time of transplantation will not develop recurrence and its predictive value should be carefully analyzed in prospective studies.